Cano Health Debt to Equity Ratio 2020-2024 | CANOQ
Current and historical debt to equity ratio values for Cano Health (CANOQ) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Cano Health debt/equity for the three months ending March 31, 2024 was 0.00.
| Cano Health Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-03-31 | $2.06B | $-1.01B | -2.04 |
| 2023-12-31 | $1.55B | $-0.54B | -2.90 |
| 2023-09-30 | $1.47B | $-0.26B | -5.68 |
| 2023-06-30 | $1.47B | $0.24B | 6.24 |
| 2023-03-31 | $1.44B | $0.50B | 2.86 |
| 2022-12-31 | $1.44B | $0.49B | 2.90 |
| 2022-09-30 | $1.41B | $0.78B | 1.81 |
| 2022-06-30 | $1.30B | $0.84B | 1.55 |
| 2022-03-31 | $1.33B | $0.84B | 1.59 |
| 2021-12-31 | $1.35B | $0.80B | 1.68 |
| 2021-09-30 | $1.28B | $0.86B | 1.49 |
| 2021-06-30 | $0.77B | $0.89B | 0.87 |
| 2021-03-31 | $0.69B | $0.01B | 137.20 |
| 2020-12-31 | $0.57B | $0.05B | 11.38 |
| 2020-09-30 | $0.69B | $0.01B | 137.43 |
| 2020-06-30 | $0.69B | $0.01B | 137.50 |
| 2020-03-31 | $0.00B | $0.00B | 0.00 |
| 2019-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.000B | $3.138B |
| Cano Health Inc. is a value-based primary care provider for seniors and underserved communities. It provides health management programs including telehealth, prescription home delivery, wellness programs, transition of care and high-risk and complex care management. Cano Health Inc., formerly known as Jaws Acquisition Corp., is based in MIAMI. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.474B | 25.66 |
| CVS Health (CVS) | United States | $117.307B | 11.70 |
| HCA Healthcare (HCA) | United States | $93.189B | 14.49 |
| Elevance Health (ELV) | United States | $89.472B | 14.04 |
| Cencora (COR) | United States | $60.778B | 18.57 |
| Natera (NTRA) | United States | $49.779B | 0.00 |
| Labcorp Holdings (LH) | United States | $26.318B | 18.55 |
| Viatris (VTRS) | United States | $19.549B | 6.75 |
| Medpace Holdings (MEDP) | United States | $17.206B | 36.13 |
| DiDi Global (DIDIY) | China | $16.502B | 181.00 |
| Revvity (RVTY) | United States | $16.261B | 27.24 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.991B | 0.00 |
| Solventum (SOLV) | United States | $15.121B | 12.51 |
| ICON (ICLR) | Ireland | $13.318B | 18.10 |
| Charles River Laboratories (CRL) | United States | $13.052B | 27.62 |
| BrightSpring Health Services (BTSG) | United States | $11.666B | 40.11 |
| Avantor (AVTR) | United States | $10.558B | 19.04 |
| BioMerieux (BMXMF) | France | $9.856B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.972B | 78.36 |
| HealthEquity (HQY) | United States | $7.941B | 25.88 |
| Sonic Healthcare (SKHHY) | Australia | $6.793B | 0.00 |
| PACS (PACS) | United States | $6.761B | 22.72 |
| GETINGE (GNGBY) | Sweden | $6.602B | 18.65 |
| MiniMed (MMED) | United States | $6.302B | 0.00 |
| CochLear (CHEOY) | Australia | $6.298B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.100B | 23.07 |
| Sotera Health (SHC) | United States | $5.516B | 22.74 |
| Concentras Parent (CON) | United States | $4.638B | 22.87 |
| Organon (OGN) | United States | $3.590B | 4.56 |
| GeneDx Holdings (WGS) | United States | $2.905B | 270.61 |
| CareDx (CDNA) | United States | $2.770B | 315.00 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.123B | 12.44 |
| Establishment Labs Holdings (ESTA) | United States | $2.121B | 0.00 |
| Progyny (PGNY) | United States | $2.101B | 29.76 |
| COMPASS Pathways (CMPS) | United Kingdom | $1.911B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.895B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.824B | 69.65 |
| Alignment Healthcare (ALHC) | United States | $1.807B | 45.84 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $1.692B | 10.16 |
| Freenome (FRNM) | United States | $1.583B | 0.00 |
| Ardent Health (ARDT) | United States | $1.512B | 8.65 |
| Agilon Health (AGL) | United States | $1.506B | 0.00 |
| Nutex Health (NUTX) | United States | $1.488B | 8.53 |
| InnovAge Holding (INNV) | United States | $1.481B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| Omada Health (OMDA) | United States | $1.210B | 247.00 |
| Teladoc Health (TDOC) | United States | $1.168B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.161B | 22.60 |
| CryoPort (CYRX) | United States | $0.836B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| GMR Solutions (GMRS) | United States | $0.701B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.462B | 0.00 |
| SBC Medicals (SBC) | United States | $0.461B | 9.53 |
| Forward Industries (FWDI) | United States | $0.444B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.387B | 5.62 |
| Shoulder Innovations (SI) | United States | $0.372B | 0.00 |
| Biodesix (BDSX) | United States | $0.301B | 0.00 |
| Embecta (EMBC) | United States | $0.291B | 2.51 |
| So-Young (SY) | China | $0.285B | 0.00 |
| LifeMD (LFMD) | United States | $0.155B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.107B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.097B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.080B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.071B | 8.37 |
| Tevogen (TVGN) | United States | $0.051B | 0.00 |
| DocGo (DCGO) | United States | $0.038B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.014B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.013B | 0.00 |
| Ainos (AIMD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.006B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.000B | 0.00 |